{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:51:41Z","timestamp":1791402701106,"version":"4.3.3"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15GPSGC24800006"],"award-info":[{"award-number":["15GPSGC24800006"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["853922"],"award-info":[{"award-number":["853922"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL131029"],"award-info":[{"award-number":["1R01HL131029"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL159243"],"award-info":[{"award-number":["K23-HL159243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24-HL153669"],"award-info":[{"award-number":["K24-HL153669"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL134893"],"award-info":[{"award-number":["R01-HL134893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL140224"],"award-info":[{"award-number":["R01-HL140224"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL160003"],"award-info":[{"award-number":["R01-HL160003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL 151841"],"award-info":[{"award-number":["R01HL 151841"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,8,16]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Eicosanoids are bioactive lipids that regulate systemic inflammation and exert vasoactive effects. Specific eicosanoid metabolites have previously been associated with pulmonary hypertension (PH), yet their role remains incompletely understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied 482 participants with chronic dyspnoea who underwent clinically indicated cardiopulmonary exercise testing (CPET) with invasive haemodynamic monitoring. We performed comprehensive profiling of 888 eicosanoids and eicosanoid-related metabolites using directed non-targeted mass spectrometry, and examined associations with PH (mean pulmonary arterial pressure (mPAP) &gt;20\u2005mmHg), PH subtypes and physiological correlates, including transpulmonary metabolite gradients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 482 participants (mean\u00b1<jats:sc>sd<\/jats:sc>age 56\u00b116\u2005years, 62% women), 200 had rest PH. We found 48 eicosanoids and eicosanoid-related metabolites that were associated with PH. Specifically, prostaglandin (11\u03b2-dhk-PGF2\u03b1), linoleic acid (12,13-EpOME) and arachidonic acid derivatives (11,12-DiHETrE) were associated with higher odds of PH (false discovery rate q&lt;0.05 for all). By contrast, epoxide (8(9)-EpETE), \u03b1-linolenic acid (13(<jats:italic>S<\/jats:italic>)-HOTrE(\u03b3)) and lipokine derivatives (12,13-DiHOME) were associated with lower odds. Among PH-related eicosanoids, 14 showed differential transpulmonary metabolite gradients, with directionality suggesting that metabolites associated with lower odds of PH also displayed pulmonary artery uptake. In individuals with exercise PH, eicosanoid profiles were intermediate between no PH and rest PH, with six metabolites that differed between rest and exercise PH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings highlight the role of specific eicosanoids, including linoleic acid and epoxide derivatives, as potential regulators of inflammation in PH. Of note, physiological correlates, including transpulmonary metabolite gradients, may prioritise future studies focused on eicosanoid-related pathways as important contributors to PH pathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.00561-2023","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:40:34Z","timestamp":1697737234000},"page":"2300561","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension"],"prefix":"10.1183","volume":"62","author":[{"given":"Jenna N.","family":"McNeill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athar","family":"Roshandelpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-9930","authenticated-orcid":false,"given":"Mona","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrush","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrooz","family":"Zarbafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8108-8240","authenticated-orcid":false,"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2024102012354128000_62.4.2300561.1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102012354128000_62.4.2300561.2","doi-asserted-by":"publisher","DOI":"10.1086\/686311"},{"key":"2024102012354128000_62.4.2300561.3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1165\/rcmb.2022-0272LE","article-title":"Sex-related differences in eicosanoid levels in chronic thromboembolic pulmonary hypertension","volume":"68","author":"Alotaibi","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102012354128000_62.4.2300561.4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0067-2015"},{"key":"2024102012354128000_62.4.2300561.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.12.018"},{"key":"2024102012354128000_62.4.2300561.6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017598"},{"key":"2024102012354128000_62.4.2300561.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750"},{"key":"2024102012354128000_62.4.2300561.8","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2024102012354128000_62.4.2300561.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2024102012354128000_62.4.2300561.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.110.959437"},{"key":"2024102012354128000_62.4.2300561.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000667"},{"key":"2024102012354128000_62.4.2300561.12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5339\/gcsp.2015.58","article-title":"Pulmonary arterial compliance: how and why should we measure it?","volume":"2015","author":"Ghio","year":"2015","journal-title":"Glob Cardiol Sci Pract"},{"key":"2024102012354128000_62.4.2300561.13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/jappl.1992.73.3.987","article-title":"A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves","volume":"73","author":"Linehan","year":"1992","journal-title":"J Appl Physiol"},{"key":"2024102012354128000_62.4.2300561.14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8769-6_2"},{"key":"2024102012354128000_62.4.2300561.15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chembiol.2018.11.015","article-title":"Directed non-targeted mass spectrometry and chemical networking for discovery of eicosanoids and related oxylipins","volume":"26","author":"Watrous","year":"2019","journal-title":"Cell Chem Biol"},{"key":"2024102012354128000_62.4.2300561.16","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800095-JLR200"},{"key":"2024102012354128000_62.4.2300561.17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bph.14196","article-title":"Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)","volume":"176","author":"Crescente","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2024102012354128000_62.4.2300561.18","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M078725"},{"key":"2024102012354128000_62.4.2300561.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000056104.49686.4B"},{"key":"2024102012354128000_62.4.2300561.20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fimmu.2013.00130","article-title":"Proinflammatory and immunoregulatory roles of eicosanoids in T cells","volume":"4","author":"Lone","year":"2013","journal-title":"Front Immunol"},{"key":"2024102012354128000_62.4.2300561.21","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9704003"},{"key":"2024102012354128000_62.4.2300561.22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3904\/kjim.1996.11.1.74","article-title":"PGF2 alpha causes bronchoconstriction and pulmonary vasoconstriction via thromboxane receptors in rat lung","volume":"11","author":"Kang","year":"1996","journal-title":"Korean J Intern Med"},{"key":"2024102012354128000_62.4.2300561.23","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/ejcts\/ezw410","article-title":"The differential effects of systemic vasoconstrictors on human pulmonary artery tension","volume":"51","author":"Hussain","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024102012354128000_62.4.2300561.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207093270202"},{"key":"2024102012354128000_62.4.2300561.25","first-page":"391","article-title":"Prostacyclin therapy for pulmonary arterial hypertension","volume":"37","author":"Ruan","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"2024102012354128000_62.4.2300561.26","doi-asserted-by":"crossref","first-page":"1063967","DOI":"10.3389\/fcvm.2022.1063967","article-title":"The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload","volume":"9","author":"Mulvaney","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024102012354128000_62.4.2300561.27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12012-019-09508-x","article-title":"Linoleic acid metabolite DiHOME decreases post-ischemic cardiac recovery in murine hearts","volume":"19","author":"Bannehr","year":"2019","journal-title":"Cardiovasc Toxicol"},{"key":"2024102012354128000_62.4.2300561.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108484"},{"key":"2024102012354128000_62.4.2300561.29","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-007-0028-x"},{"key":"2024102012354128000_62.4.2300561.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.04.018"},{"key":"2024102012354128000_62.4.2300561.31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00953.2005"},{"key":"2024102012354128000_62.4.2300561.32","first-page":"H100","article-title":"5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog","volume":"275","author":"Stephenson","year":"1998","journal-title":"Am J Physiol"},{"key":"2024102012354128000_62.4.2300561.33","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.2001.280.1.H1","article-title":"The lung HETEs (and EETs) up","volume":"280","author":"Jacobs","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024102012354128000_62.4.2300561.34","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1038\/s41467-022-30621-z","article-title":"Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling","volume":"13","author":"Moriyama","year":"2022","journal-title":"Nat Commun"},{"key":"2024102012354128000_62.4.2300561.35","doi-asserted-by":"crossref","first-page":"31649","DOI":"10.1038\/srep31649","article-title":"15-Lipoxygenase metabolites of alpha-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci Rep"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00561-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:17:01Z","timestamp":1740381421000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00561-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10,19]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1183\/13993003.00561-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00561-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}